Year: 2025
Type: review
Abstract: The kynurenine (KYN) metabolic pathway sits at the crossroads of immunity, metabolism, and neurobiology, yet its clinical translation remains fragmented. Emerging spatial omics, wearable chronobiology, and synthetic microbiota studies reveal that tryptophan (Trp) metabolism is regulated by distinct cellular "checkpoints" along the gut-brain axis, finely modulated by sex differences, circadian rhythms, and microbiome composition. However, current interventions tackle single levers in isolation, leaving a key gap in the precision control of Trp's fate. To address this, we drew upon an extensive body of the primary literature and databases, mapping enzyme expression across tissues at single-cell resolution and linking these profiles to clinical trials investigating dual indoleamine 2,3-dioxygenase 1 (IDO1)/tryptophan 2,3-dioxygenase (TDO) inhibitors, engineered probiotics, and chrono-modulated dosing strategies. We then developed decision-tree algorithms that rank therapeutic combinations against biomarker feedback loops derived from real-time saliva, plasma, and stool metabolomics. This synthesis pinpoints microglial and endothelial KYN hotspots, quantifies sex-specific chronotherapeutic windows, and identifies engineered Bifidobacterium consortia and dual inhibitors as synergistic nodes capable of reducing immunosuppressive KYN while preserving neuroprotective kynurenic acid. Here, we highlight a framework that couples lifestyle levers, bio-engineered microbes, and adaptive pharmaco-regimens into closed-loop "smart protocols." By charting these intersections, this study offers a roadmap for biomarker-guided, multidisciplinary interventions that could recalibrate KYN metabolic activity across cancer, mood, neurodegeneration, and metabolic disorders, appealing to clinicians, bioengineers, and systems biologists alike.
Source: Biomedicines
Authors: Masaru Tanaka, László Vécsei
Institutions: University of Szeged, Hungarian Research Network
Language: English
Subfield: Biological Psychiatry
Field: Neuroscience
Domain: Life Sciences
Keywords: kynurenine pathway, tryptophan metabolism, gut-brain axis, IDO1, tryptophan 2,3-dioxygenase, kynurenic acid, engineered probiotics, Bifidobacterium, circadian rhythm, chronotherapy, sex differences, microglia, endothelial cells, metabolomics biomarkers, decision tree, cancer, mood disorders, neurodegeneration, metabolic disorders
Open Access status: gold
Estimated APC paid: $3,137
Awards: G2326201979, G5823049995, G6589236725
OpenAlex ID: W4413329354
